UPLOAD Filing
PTC THERAPEUTICS, INC.
Date: Sept. 24, 2025 · CIK: 0001070081 · Accession: 0000000000-25-010381
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 001-35969
Letter
Re: PTC Therapeutics, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 Filed February 27, 2025 File No. 001-35969 Dear Pierre Gravier:
September 24, 2025
Pierre Gravier Chief Financial Officer PTC Therapeutics, Inc. 500 Warren Corporate Center Drive Warren, NJ 07059
We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Sincerely,
Division of Corporation
Finance
Office of Life Sciences
Show Raw Text
<DOCUMENT> <TYPE>TEXT-EXTRACT <SEQUENCE>2 <FILENAME>filename2.txt <TEXT> September 24, 2025 Pierre Gravier Chief Financial Officer PTC Therapeutics, Inc. 500 Warren Corporate Center Drive Warren, NJ 07059 Re: PTC Therapeutics, Inc. Form 10-K for Fiscal Year Ended December 31, 2024 Filed February 27, 2025 File No. 001-35969 Dear Pierre Gravier: We have completed our review of your filing. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Sincerely, Division of Corporation Finance Office of Life Sciences </TEXT> </DOCUMENT>